Final answer:
The elevated prolactin level suggests that the most appropriate next step in managing the patient's subfertility is to begin bromocriptine, which is a medication that can lower prolactin levels and potentially restore ovulation.
Step-by-step explanation:
The case of a 37-year-old G2P1 experiencing subfertility points out a key abnormality in her laboratory results: her prolactin level is elevated at 60 ng/ml, which is above the normal value of less than 20 ng/ml. This high level of prolactin can inhibit ovulation, leading to irregular menstrual cycles and subfertility. Considering the patient's symptoms and lab results, the most appropriate next step in managing this patient's subfertility would be A. Begin bromocriptine. Bromocriptine is a dopamine agonist that can help to lower prolactin levels, thus potentially restoring normal ovulatory cycles and improving chances of conception.
It is important to note that while imipramine, a tricyclic antidepressant that the patient continues to take, may cause side effects, there's no indication from the question that this medication is contributing to the subfertility, hence C. Wean off imipramine is not the immediate step. Moreover, there is no mention of symptoms that would indicate a visual field defect, so D. Perform a visual field examination, and E. Obtain a brain MRI would be less likely next steps without such evidence. The use of ovulation induction with clomiphene citrate (Clomid) might be an option if the prolactin levels were normal and if there was evidence of anovulation, but that is not the case here based on the abnormal prolactin levels.